Hello everyone! My name is Kramer Kaplan, and I am a current graduate student working on fish genetics. My advisor and I are learning how to go through the process of 2D sequencing to obtain the entire mitochondrial genome of two species of freshwater stingrays. I wanted to submit a post here with several questions that I had. We have been using a PCR Barcoding Kit (EXP-PBC001) that has the twelve barcodes and barcode adapter mixes (BCA). I was wondering when you use that adapter mix because it does not say anything about that in the protocol. I'm following the "PCR barcoding amplicon sequencing for the MinION device using SQK-NSK007." As I have been following this protocol, the issue I have been seeing is my concentrations of DNA keep getting less and less until I have less than 20ng/ul. Before prepping the MinION, I am supposed to have around 150ng/ul of material. My first found PCR product showed about 10kB on a gel, and the concentrations were high enough, so I truly do not know what the issue is. If anyone could shed some light on these issues or offer any advice, that would be greatly appreciated!
-
-
Hi! You can ligate the BCA to any DNA and then do a barcoded PCR, e.g if you want to use genomic DNA or have amplicons without the ONT pcr-priming tail. We also tend to get lower than recommended yield of DNA after the final streptavidin bead purification, but I think 20 ng/ul is still high. If you only get 20 ng in total then something is likely wrong, perhaps adaptors are too old or your starting concentration was off.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment